Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Inactivation of SARS coronavirus by means of povidone-lodine, physical conditions and chemical reagents

Identifieur interne : 004440 ( Main/Exploration ); précédent : 004439; suivant : 004441

Inactivation of SARS coronavirus by means of povidone-lodine, physical conditions and chemical reagents

Auteurs : Hiroaki Kariwa [Japon] ; Nobuhiro Fujii [Japon] ; Ikuo Takashima [Japon]

Source :

RBID : Pascal:06-0170112

Descripteurs français

English descriptors

Abstract

The efficacy of several povidone-iodine (PVP-I) products, a number of other chemical agents and various physical conditions were evaluated for their ability to inactivate the severe acute respiratory syndrome coronavirus (SARS-CoV). Treatment of SARS-CoV with PVP-I products for 2 min reduced the virus infectivity from 1.17 x 106 TCID50/ml to below the detectable level. The efficacy of 70% ethanol was equivalent to that of PVP-I products. Fixation of SARS-CoV-infected Vero E6 cells with a fixative including formalin, glutaraldehyde, methanol and acetone for 5 min or longer eliminated all infectivity. Heating the virus at 56°C for 60 min or longer reduced the infectivity of the virus from 2.6 x 107 to undetectable levels. Irradiation with ultraviolet light at 134 μW/cm2 for 15 min reduced the infectivity from 3.8 x 107 to 180 TCID50/ml; however, prolonged irradiation (60 min) failed to eliminate the remaining virus, leaving 18.8 TCID50/ml.


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Inactivation of SARS coronavirus by means of povidone-lodine, physical conditions and chemical reagents</title>
<author>
<name sortKey="Kariwa, Hiroaki" sort="Kariwa, Hiroaki" uniqKey="Kariwa H" first="Hiroaki" last="Kariwa">Hiroaki Kariwa</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Laboratory of Public Health, Graduate School of Veterinary Medicine, Hokkaido University</s1>
<s2>Sapporo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<wicri:noRegion>Sapporo</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Fujii, Nobuhiro" sort="Fujii, Nobuhiro" uniqKey="Fujii N" first="Nobuhiro" last="Fujii">Nobuhiro Fujii</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Microbiology, School of Medicine, Sapporo Medical University</s1>
<s2>Sapporo</s2>
<s3>JPN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<wicri:noRegion>Sapporo</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Takashima, Ikuo" sort="Takashima, Ikuo" uniqKey="Takashima I" first="Ikuo" last="Takashima">Ikuo Takashima</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Laboratory of Public Health, Graduate School of Veterinary Medicine, Hokkaido University</s1>
<s2>Sapporo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<wicri:noRegion>Sapporo</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">06-0170112</idno>
<date when="2006">2006</date>
<idno type="stanalyst">PASCAL 06-0170112 INIST</idno>
<idno type="RBID">Pascal:06-0170112</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000534</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000456</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000462</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000462</idno>
<idno type="wicri:doubleKey">1018-8665:2006:Kariwa H:inactivation:of:sars</idno>
<idno type="wicri:Area/Main/Merge">004663</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:16490989</idno>
<idno type="wicri:Area/PubMed/Corpus">002337</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002337</idno>
<idno type="wicri:Area/PubMed/Curation">002337</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002337</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002146</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002146</idno>
<idno type="wicri:Area/Ncbi/Merge">001387</idno>
<idno type="wicri:Area/Ncbi/Curation">001387</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001387</idno>
<idno type="wicri:doubleKey">1018-8665:2006:Kariwa H:inactivation:of:sars</idno>
<idno type="wicri:Area/Main/Merge">004038</idno>
<idno type="wicri:Area/Main/Curation">004440</idno>
<idno type="wicri:Area/Main/Exploration">004440</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Inactivation of SARS coronavirus by means of povidone-lodine, physical conditions and chemical reagents</title>
<author>
<name sortKey="Kariwa, Hiroaki" sort="Kariwa, Hiroaki" uniqKey="Kariwa H" first="Hiroaki" last="Kariwa">Hiroaki Kariwa</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Laboratory of Public Health, Graduate School of Veterinary Medicine, Hokkaido University</s1>
<s2>Sapporo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<wicri:noRegion>Sapporo</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Fujii, Nobuhiro" sort="Fujii, Nobuhiro" uniqKey="Fujii N" first="Nobuhiro" last="Fujii">Nobuhiro Fujii</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Microbiology, School of Medicine, Sapporo Medical University</s1>
<s2>Sapporo</s2>
<s3>JPN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<wicri:noRegion>Sapporo</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Takashima, Ikuo" sort="Takashima, Ikuo" uniqKey="Takashima I" first="Ikuo" last="Takashima">Ikuo Takashima</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Laboratory of Public Health, Graduate School of Veterinary Medicine, Hokkaido University</s1>
<s2>Sapporo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<wicri:noRegion>Sapporo</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Dermatology : (Basel)</title>
<title level="j" type="abbreviated">Dermatology : (Basel)</title>
<idno type="ISSN">1018-8665</idno>
<imprint>
<date when="2006">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Dermatology : (Basel)</title>
<title level="j" type="abbreviated">Dermatology : (Basel)</title>
<idno type="ISSN">1018-8665</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Acetone (pharmacology)</term>
<term>Animals</term>
<term>Anti-Infective Agents, Local (pharmacology)</term>
<term>Antiviral</term>
<term>Antiviral Agents (pharmacology)</term>
<term>Biological activity</term>
<term>Chlorocebus aethiops</term>
<term>Coronavirus</term>
<term>Ethanol (pharmacology)</term>
<term>Formaldehyde (pharmacology)</term>
<term>Glutaral (pharmacology)</term>
<term>Hot Temperature</term>
<term>In vitro</term>
<term>Indicators and Reagents (pharmacology)</term>
<term>Iodine</term>
<term>Methanol (pharmacology)</term>
<term>Povidone</term>
<term>Povidone-Iodine (pharmacology)</term>
<term>SARS Virus (drug effects)</term>
<term>SARS Virus (radiation effects)</term>
<term>Severe acute respiratory syndrome</term>
<term>Ultraviolet Rays</term>
<term>Vero Cells</term>
<term>Virus Inactivation</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Acétone (pharmacologie)</term>
<term>Animaux</term>
<term>Anti-infectieux locaux (pharmacologie)</term>
<term>Antiviraux (pharmacologie)</term>
<term>Cellules Vero</term>
<term>Formaldéhyde (pharmacologie)</term>
<term>Glutaraldéhyde (pharmacologie)</term>
<term>Inactivation virale</term>
<term>Indicateurs et réactifs (pharmacologie)</term>
<term>Méthanol (pharmacologie)</term>
<term>Povidone iodée (pharmacologie)</term>
<term>Rayons ultraviolets</term>
<term>Température élevée</term>
<term>Virus du SRAS ()</term>
<term>Virus du SRAS (effets des radiations)</term>
<term>Éthanol (pharmacologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Acetone</term>
<term>Anti-Infective Agents, Local</term>
<term>Antiviral Agents</term>
<term>Ethanol</term>
<term>Formaldehyde</term>
<term>Glutaral</term>
<term>Indicators and Reagents</term>
<term>Methanol</term>
<term>Povidone-Iodine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des radiations" xml:lang="fr">
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Acétone</term>
<term>Anti-infectieux locaux</term>
<term>Antiviraux</term>
<term>Formaldéhyde</term>
<term>Glutaraldéhyde</term>
<term>Indicateurs et réactifs</term>
<term>Méthanol</term>
<term>Povidone iodée</term>
<term>Éthanol</term>
</keywords>
<keywords scheme="MESH" qualifier="radiation effects" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Chlorocebus aethiops</term>
<term>Hot Temperature</term>
<term>Ultraviolet Rays</term>
<term>Vero Cells</term>
<term>Virus Inactivation</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Animaux</term>
<term>Cellules Vero</term>
<term>Inactivation virale</term>
<term>Rayons ultraviolets</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Povidone</term>
<term>Coronavirus</term>
<term>Iode</term>
<term>In vitro</term>
<term>Activité biologique</term>
<term>Antiviral</term>
<term>Température élevée</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Iode</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The efficacy of several povidone-iodine (PVP-I) products, a number of other chemical agents and various physical conditions were evaluated for their ability to inactivate the severe acute respiratory syndrome coronavirus (SARS-CoV). Treatment of SARS-CoV with PVP-I products for 2 min reduced the virus infectivity from 1.17 x 10
<sup>6</sup>
TCID
<sub>50</sub>
/ml to below the detectable level. The efficacy of 70% ethanol was equivalent to that of PVP-I products. Fixation of SARS-CoV-infected Vero E6 cells with a fixative including formalin, glutaraldehyde, methanol and acetone for 5 min or longer eliminated all infectivity. Heating the virus at 56°C for 60 min or longer reduced the infectivity of the virus from 2.6 x 10
<sup>7</sup>
to undetectable levels. Irradiation with ultraviolet light at 134 μW/cm
<sup>2</sup>
for 15 min reduced the infectivity from 3.8 x 10
<sup>7</sup>
to 180 TCID
<sub>50</sub>
/ml; however, prolonged irradiation (60 min) failed to eliminate the remaining virus, leaving 18.8 TCID
<sub>50</sub>
/ml.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Japon</li>
</country>
</list>
<tree>
<country name="Japon">
<noRegion>
<name sortKey="Kariwa, Hiroaki" sort="Kariwa, Hiroaki" uniqKey="Kariwa H" first="Hiroaki" last="Kariwa">Hiroaki Kariwa</name>
</noRegion>
<name sortKey="Fujii, Nobuhiro" sort="Fujii, Nobuhiro" uniqKey="Fujii N" first="Nobuhiro" last="Fujii">Nobuhiro Fujii</name>
<name sortKey="Takashima, Ikuo" sort="Takashima, Ikuo" uniqKey="Takashima I" first="Ikuo" last="Takashima">Ikuo Takashima</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004440 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004440 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:06-0170112
   |texte=   Inactivation of SARS coronavirus by means of povidone-lodine, physical conditions and chemical reagents
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021